SCA Pharmaceuticals is recalling 4,843 syringes of Fentanyl injection (250 mcg/ 5mL) because testing revealed the medication may be less potent than required. This recall affects various lots of the drug that were distributed to three hospitals in Missouri and Louisiana. Because this is a prescription medication used for pain management, patients who may have received this product should consult their healthcare provider or pharmacist.
The medication was found to be 'subpotent,' meaning it contains less of the active ingredient than specified. If the drug is not at full strength, patients may receive an inadequate dose of pain medication, leading to poorly controlled pain or other complications during medical procedures.
Healthcare provider consultation and pharmacy refund.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.